GROWTH FACTORS FOR RAT MAMMARY CANCER

NIH RePORTER · NIH · R01 · $141,012 · view on reporter.nih.gov ↗

Abstract

Rat mammary tumor MTW9 can be grown in rats coimplanted with a mammosomatotropic tumor MtTW10 which secretes a factor which prevents ovariectomy-induced regression (OIR). We called this factor galactomedin. The factor is not prolactin, GH, ACTH or any other known steroid. An assay for this activity is possible based upon prevention of ovariectomy induced regression in the hormonally responsive rat tumor-MTW9-D, by injection of serum from MtTW10 bearing rat into ovariectomized-MTW9-rats. Basic extracts from MtTW10 tumor inhibit the growth of MTW9 cell cultures. If this inhibition represents the putative galactomedin the in vitro assay will be used in an effort to isolate galactomedin; if the activity is not identical, the in vivo activity, though expensive and slow, is adequate for the isolation of galactomedin.

Key facts

NIH application ID
3170481
Project number
5R01CA032581-04
Recipient
MOUNT SINAI SCHOOL OF MEDICINE OF CUNY
Principal Investigator
VINCENT P. HOLLANDER
Activity code
R01
Funding institute
NIH
Fiscal year
1987
Award amount
$141,012
Award type
5
Project period
1981-12-01 → 1987-12-31